Allovirinc Stock Current Ratio
| ALVR Stock | USD 0.78 0.01 1.27% |
AllovirInc fundamentals help investors to digest information that contributes to AllovirInc's financial success or failures. It also enables traders to predict the movement of AllovirInc Stock. The fundamental analysis module provides a way to measure AllovirInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AllovirInc stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 6.61 | 6.28 |
AllovirInc | Current Ratio |
AllovirInc Company Current Ratio Analysis
AllovirInc's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current AllovirInc Current Ratio | 8.18 X |
Most of AllovirInc's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AllovirInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
AllovirInc Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for AllovirInc is extremely important. It helps to project a fair market value of AllovirInc Stock properly, considering its historical fundamentals such as Current Ratio. Since AllovirInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AllovirInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AllovirInc's interrelated accounts and indicators.
Click cells to compare fundamentals
AllovirInc Current Ratio Historical Pattern
Today, most investors in AllovirInc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AllovirInc's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AllovirInc current ratio as a starting point in their analysis.
AllovirInc Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
AllovirInc Price To Sales Ratio
Price To Sales Ratio |
|
In accordance with the recently published financial statements, AllovirInc has a Current Ratio of 8.18 times. This is 181.1% higher than that of the Biotechnology sector and 16.86% higher than that of the Health Care industry. The current ratio for all United States stocks is notably lower than that of the firm.
AllovirInc Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AllovirInc's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AllovirInc could also be used in its relative valuation, which is a method of valuing AllovirInc by comparing valuation metrics of similar companies.AllovirInc is currently under evaluation in current ratio category among related companies.
AllovirInc Current Valuation Drivers
We derive many important indicators used in calculating different scores of AllovirInc from analyzing AllovirInc's financial statements. These drivers represent accounts that assess AllovirInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of AllovirInc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.7B | 1.0B | 812.4M | 393.2M | 70.7M | 67.2M | |
| Enterprise Value | 1.6B | 920.0M | 640.8M | 322.5M | 8.0M | 7.6M |
AllovirInc Fundamentals
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | (68.24 M) | ||||
| Shares Outstanding | 114.87 M | ||||
| Shares Owned By Insiders | 48.95 % | ||||
| Shares Owned By Institutions | 42.93 % | ||||
| Number Of Shares Shorted | 6.3 M | ||||
| Price To Book | 0.60 X | ||||
| Gross Profit | 165 K | ||||
| EBITDA | (180.93 M) | ||||
| Net Income | (190.42 M) | ||||
| Cash And Equivalents | 172.67 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 27.43 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 1.31 X | ||||
| Cash Flow From Operations | (124.45 M) | ||||
| Short Ratio | 12.99 X | ||||
| Earnings Per Share | (1.83) X | ||||
| Price To Earnings To Growth | (0.06) X | ||||
| Target Price | 1.0 | ||||
| Number Of Employees | 112 | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 90.85 M | ||||
| Total Asset | 190.8 M | ||||
| Retained Earnings | (656.19 M) | ||||
| Working Capital | 159.27 M | ||||
| Current Asset | 61.62 M | ||||
| Current Liabilities | 53.23 M | ||||
| Net Asset | 190.8 M |
About AllovirInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AllovirInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AllovirInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AllovirInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AllovirInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AllovirInc's short interest history, or implied volatility extrapolated from AllovirInc options trading.
Pair Trading with AllovirInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AllovirInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AllovirInc will appreciate offsetting losses from the drop in the long position's value.Moving together with AllovirInc Stock
| 0.73 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.8 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
Moving against AllovirInc Stock
| 0.52 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
The ability to find closely correlated positions to AllovirInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AllovirInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AllovirInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AllovirInc to buy it.
The correlation of AllovirInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AllovirInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AllovirInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AllovirInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AllovirInc Piotroski F Score and AllovirInc Altman Z Score analysis. To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for AllovirInc Stock analysis
When running AllovirInc's price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.83) | Return On Assets (0.48) | Return On Equity (1.03) |
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if AllovirInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.